Insulin Detemir and Levemir and Xultophy — marketed mostly in the format of pre-filled disposable pen and cartridges (Penfill and FlexPen). The company recently informed its marketing partner ...

The discontinuation will also affect other products in the Rs 5,000 crore insulin market like Actrapid, Insulatard, Insulin Detemir, Levemir, and Xultophy, primarily available in pre-filled disposable ...

Insulin as part (rDNA origin) injection Novolog (Novo Nordisk) 28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis ...

The FDA approved Merilog (insulin-aspart-szjj) as the first biosimilar to reference Novolog (insulin aspart) for the treatment of adult and pediatric patients with type 2 diabetes. In 2024, the FDA ...

Novo Nordisk will start slashing some U.S. insulin prices up to 75% next year, following a path set earlier this month by ...